Lv62
2650 积分 2023-03-11 加入
The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B‐cell acute lymphoblastic leukemia patients detected by next‐generation sequencing
4个月前
已完结
A chemiluminescence immunoassay for the detection of NT-proBNP
7个月前
已完结
Nanozymes
8个月前
已完结
Nanozymology
8个月前
已完结
Biosafety and biocompatibility assessment of Prussian blue nanoparticles in vitro and in vivo
9个月前
已完结
The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center
1年前
已关闭
Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study
1年前
已关闭
A Phase II Study of Low-Intensity Chemotherapy (Mini-Hyper-CVD) and Ponatinib Followed By Blinatumomab and Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
1年前
已关闭
[Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study]
1年前
已完结
Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin’s Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study
1年前
已完结
皖公网安备34019202002308
